Genotyping and Molecular Characterization of Fluoroquinolone's Resistance Among Multidrug-Resistant Mycobacterium tuberculosis in Southwest of China
- 16 July 2021
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 27 (7) , 865-870
Abstract
Although fluoroquinolones (FQs) are the backbone drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB), the knowledge about the resistance pattern and molecular characterization of new-generation FQs in Chongqing is limited. This study aimed to investigate the resistance rate and mutation types of later-generation FQs against MDR-TB in Chongqing, and further to explore the relationship between different genotypes and phenotypes. A total of 967 clinical strains were characterized using multilocus sequence typing and drug susceptibility testing, followed by analysis of genotype/phenotype association. The 229 (23.7%, 229/967) isolates were identified as MDR-TB. The most effective agent against MDR-TB was gatifloxacin (GFX) (20.1%, 46/229), and the highest resistant rate was observed in ofloxacin (OFX) (41.0%, 94/229). Of the 190 strains (83.0%) identified as Beijing genotype, 111 isolates were modern Beijing genotype (58.4%) and 79 isolates were ancient Beijing genotype (41.6%). By analyzing 94 OFX-resistant isolates, 13 isolates were clustered with the cumulative clustering rate of 13.8% (13/94). Of the 91 isolates (39.7%, 91/229) with a mutation in gyrA gene, mutation in codon 94 was the most prevalent. Only 15 isolates (6.6%, 15/229) harbored a mutation in gyrB gene. There was no significant difference in the mutation rate of gyrA gene between Beijing and non-Beijing genotype, clustered isolates, and nonclustered isolates ( p > 0.05).Keywords
This publication has 24 references indexed in Scilit:
- Mycobacterium tuberculosis Beijing Strains Favor Transmission but Not Drug Resistance in ChinaClinical Infectious Diseases, 2012
- Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, ChinaJournal of Clinical Microbiology, 2012
- National Survey of Drug-Resistant Tuberculosis in ChinaNew England Journal of Medicine, 2012
- Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosisisolates from East China in 2009BMC Infectious Diseases, 2011
- First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospitalClinical Microbiology and Infection, 2010
- Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in ChinaJournal of Infection, 2010
- Genetic diversity of theMycobacterium tuberculosisBeijing family in East Asia revealed through refined population structure analysisFEMS Microbiology Letters, 2009
- Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing ofMycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Identification of Mycobacterial Species by PCR Sequencing of Quinolone Resistance-Determining Regions of DNA Gyrase GenesJournal of Clinical Microbiology, 2003
- Molecular Characterization of Multidrug-Resistant Isolates of Mycobacterium tuberculosis from Patients in North IndiaAntimicrobial Agents and Chemotherapy, 2002